DUBLIN , June 23, 2022 /PRNewswire/ -- The "Global Injectable Drug Delivery Devices Market Report 2022" report has been added to ResearchAndMarkets.com's offering.
The global injectable drug delivery devices market is expected to grow from $34.49 billion in 2021 to $38.03 billion in 2022 at a compound annual growth rate (CAGR) of 10.3%. The market is expected to grow to $55.89 billion in 2026 at a compound annual growth rate (CAGR) of 10.1%.
Injectable Drug Delivery Devices Global Market Report 2022 provides the strategists, marketers and senior management with the critical information they need to assess the global injectable drug delivery devices market.
Major players in the injectable drug delivery devices market are Becton, Dickinson and Company, Gerresheimer AG, Eli Lilly and Company, Pfizer Inc, Teva Pharmaceutical Industries Ltd, Schott AG, Baxter International, Owen Mumford , Mylan N.V., and Sanofi. The injectable drug delivery devices market consists of sales of conventional syringes, needle-free injectors, auto-injectors, and pen injectors. These are used for various routes of drug administration, such as intravenous, subcutaneous, intradermal, intraperitoneal, and intramuscular, and others to treat medical conditions ranging from cancer to autoimmune disorders. The main types of injectable drug delivery devices are conventional injectable, pre-filled syringes, auto-injectors, and pen-injectors. The prefilled syringes are the packaging with the fixed needle that contains single-dose vaccines or other medications. The injectable drug delivery devices offer applications such as autoimmune diseases, hormonal disorders, oncology, orphan diseases, pain management, respiratory therapy, and others that are used by various end-users such as hospitals and clinics, home healthcare settings, pharmaceutical and biotechnological companies, research laboratories, and others. North America was the largest region in the injectable drug delivery devices market in 2021. Western Europe was the second-largest region in the injectable drug delivery devices market. The regions in this report are Asia-Pacific , Western Europe , Eastern Europe , North America , South America , Middle East , and Africa . The increasing preference for self-injection devices is driving the injectable drug delivery devices market. Self-injection devices are medical devices that can be used by the patient in-home setting for self-administration of the medication. Self-injection devices include needle-free, auto, pen, and wearable injectors.
These self-injectables were developed to provide the most adaptable device which has a high precision of drug delivery and is easy to use. In addition, with the innovations in self-injectable devices, the acceptance of these products has increased over the past few years.
BD Physioject is a disposable auto-injector, manufactured by Becton, Dickinson, and Company, which is clinically proven, reliable, and cost-effective specifically designed for self-injection of drugs by patients suffering from chronic diseases, including rheumatoid arthritis, multiple sclerosis, asthma, and osteoporosis.
The other companies currently involved in the self-injections market include Abbvie, Inc., 3M , Baxter, Gerresheimer AG, Pfizer Inc, and more. The advantages of self-injectable injections and increasing awareness of self-administration have increased the demand for self-injectable devices and will drive the injectable drug delivery devices market during the forecast period. The emergence of alternative drug delivery devices to injectable drug delivery devices is negatively affecting the market. Injectable (parenteral) drug delivery is one of the widely used conventional drug delivery systems. There are many alternative (painless) drug delivery systems such as nasal, transdermal, transmucosal, vaginal, anal, and others that are evolving.
The selection of a drug delivery system depends on the drug release, absorption, distribution, metabolism, and elimination profile of the therapeutic agent to achieve the highest level of safety and efficacy from the drug. Alternative drug delivery systems hold key importance in improving bioavailability, reducing toxicity, and safety elimination of drug which is administered to treat a particular disease.
Growing disease-related complications, regular developments in drugs, and combinations of therapeutic agents are used to treat disease driving the need for alternative drug delivery systems. There are some recent ongoing developments in the field of alternative drug delivery systems mainly in a nanoparticles-based delivery system, intracellular delivery system, neural delivery system, and many more. Thus, the emergence of alternative drug delivery methods limits the growth of the injectable drug delivery devices market. The companies in injectable drug delivery devices are increasingly focusing on the manufacturing of auto-injectors. The auto-injectors are fully automated, highly customized, and reusable injectors that can be used by a patient to perform hundreds of injections. Patients can control the speed of dose delivery to help minimize pain or discomfort during injection. These devices can adjust the speed and depth of the automatic injection.
For instance, LISA, a reusable auto-injector manufactured by Unilife corporation comes with an array of highly customizable features including Bluetooth LE connectivity, Wi-Fi or 3G connectivity, and pre-injection drug warming for target therapies. The injectable drug delivery technology market is expected to show significant growth in the coming years, due to various technological advancements and new product launches to improve the convenience and ease of administration of parenteral therapeutics. Key Topics Covered: 1. Executive Summary 2. Injectable Drug Delivery Devices Market Characteristics 3. Injectable Drug Delivery Devices Market Trends And Strategies 4. Impact Of COVID-19 On Injectable Drug Delivery Devices 5. Injectable Drug Delivery Devices Market Size And Growth 5.1. Global Injectable Drug Delivery Devices Historic Market, 2016-2021, $ Billion 5.1.1. Drivers Of The Market 5.1.2. Restraints On The Market 5.2. Global Injectable Drug Delivery Devices Forecast Market, 2021-2026F, 2031F, $ Billion 5.2.1. Drivers Of The Market 5.2.2. Restraints On the Market 6. Injectable Drug Delivery Devices Market Segmentation 6.1. Global Injectable Drug Delivery Devices Market, Segmentation By Type, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
6.2. Global Injectable Drug Delivery Devices Market, Segmentation By Application, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
6.3. Global Injectable Drug Delivery Devices Market, Segmentation By End User, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
7. Injectable Drug Delivery Devices Market Regional And Country Analysis 7.1. Global Injectable Drug Delivery Devices Market, Split By Region, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion 7.2. Global Injectable Drug Delivery Devices Market, Split By Country, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion Companies Mentioned
For more information about this report visit https://www.researchandmarkets.com/r/i4qjwx
Research and Markets Laura Wood , Senior Manager press@researchandmarkets.com
For E.S.T Office Hours Call +1-917-300-0470 For U.S./CAN Toll Free Call +1-800-526-8630 For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907 Fax (outside U.S.): +353-1-481-1716
Logo: https://mma.prnewswire.com/media/539438/Research_and_Markets_Logo.jpg
View original content:https://www.prnewswire.com/news-releases/global-injectable-drug-delivery-devices-market-report-2022-a-55-89-billion-market-in-2026---long-term-forecast-to-2031--301573851.html
Russia’s fiddling with gas flows to Europe could create an economic spillover effect, warns Germany’s top economy minister.
(Bloomberg) -- The prolonged slump in Bitcoin is making it more difficult for some miners to repay the up to $4 billion in loans they have backed by their equipment, posing a potential risk to major crypto lenders.Most Read from BloombergSupreme Court Overturns Roe, Transforming Abortion-Rights FightStocks Roar Back With Best Week in a Month: Markets WrapJuul’s Vaping Products Are Ordered Off the Market in the USJustice Kavanaugh Says States May Not Bar Travel to Obtain an AbortionProtest Latest
Palantir Technologies went public in late 2020 and got lots of attention from the wallstreetbets crowd for a while. The company sells software and services to corporations and governments seeking to solve problems using data analysis.
Toyota Motor shares slipped after it recalled some of its first mass-made all-electric cars, launched two months ago, because of a risk of wheels coming loose, a setback to its ambitions to electrify its model range. Toyota, the world's largest automaker by sales, said on Thursday it would recall 2,700 bZ4X SUVs globally. Subaru Corp, in which Toyota has a nearly 20% stake, also said it was recalling about 2,600 units of the Solterra, a related model.
GasBuddy Head of Petroleum Analysis Patrick De Haan joins Yahoo Finance Live to discuss why gas costs so much, forecasts for lowering gas prices, President Biden's proposed federal gas tax holiday, and travel trends.
(Bloomberg) -- The US energy chief struck a conciliatory tone in a high-stakes meeting with top oil executives to discuss soaring gasoline prices on Thursday, though the huddle yielded little progress on a plan to address the supply crunch. Most Read from BloombergJuul’s Vaping Products Are Ordered Off the Market in the USElon Musk Says New Tesla Plants Are ‘Money Furnaces’ Losing BillionsThese Are the World’s Most Liveable Cities in 2022Recession Worries Boost Treasuries; Stocks Advance: Market
"The current real estate market provides the opportunity to right-size our office space to meet the requirements of our headquarters-based employee population," the company said in an email. Chevron is expected to shift its headquarters to the new site during the third quarter of 2023. Rival Exxon in January also relocated its corporate headquarters from Irving, Texas to its campus north of Houston.
Berkshire Hathaway (NYSE: BRK.A)(NYSE: BRK.B) CEO Warren Buffett has a knack for making money. Despite navigating his way through more than a half-dozen bear markets since taking the reins in 1965, the Oracle of Omaha has created more than $590 billion in shareholder value and overseen a better than 3,600,000% aggregate return for his company's Class A shares (BRK.A). Warren Buffett's success as an investor is the result of a long list of factors, including his love of dividend-paying stocks and time-tested businesses that can outperform in virtually any economic environment.
When Russia turns off the gas through the Nord Stream 1 pipeline for maintenance in July, Europe is starting to worry that it won't turn it back on again. This week, Russia cut gas flows to Europe to 40% of the pipeline's capacity, blaming delayed equipment repairs and leaving Germany and other European states racing to find alternative supplies to head off the risk of rationing when winter comes. Now, Europe fears President Vladimir Putin will use a scheduled maintenance programme on the pipeline from July 11 to 21 to turn the screws, putting a brake on efforts to refill inventories in retaliation for far-reaching sanctions over Moscow's invasion of Ukraine.
DEEP DIVE This year’s stock price declines make for an increasing number of stocks with high dividend yields of at least 5%. Below is a screen that highlights 29 that appear to be able to raise their payouts considerably.
The German government is considering converting parts of the Nord Stream 2 gas pipeline into a connection for a liquefied natural gas terminal on the Baltic Sea coast. Magazine Der Spiegel reported on Friday that the German economy ministry is considering expropriating the part of the pipeline system located on German territory and cutting it off from the rest of the pipeline. Russia said it would be a matter for lawyers if Germany took such steps.
Tesla CEO Elon Musk spoke with a Tesla owners club. He talked bankruptcy, advertising, full self driving, and birthrates. There was a lot to digest.
Intel still plans to build the facility, but the scope and pace of its expansion in Ohio would heavily depend on the amount of funding from Congress.
In a redirection of flows because of the Ukraine war, America is selling more to Europe, while Russia is becoming more dependent on sales to China.
The bZ4X losing its wheels is perhaps the best metaphor for a company that became complacent after revolutionizing the industry with its Prius hybrid and is now rushing to catch up to Tesla.
Prices have been boosted by a Biden administration mandate to blend more of the biofuel into gasoline and some of the highest U.S. consumer inflation in decades.
OPEC and its allies, known as OPEC+, is set to meet June 30 to decide on oil production levels. But it’s having trouble reaching its target to pump more crude.
Tough times are coming. Prep your portfolio.
Worried about falling profits and high fixed costs, investors have been dumping publicly traded bitcoin miners like Riot Blockchain and TeraWulf amid the cryptocurrency selloff.
These are the materials stocks with the best value, fastest growth, and most momentum for July 2022.